A brand manager hears that a competitor has been named in a complaint to the pharmaceutical association over a promotional claim. The first question in the room is what actually happens next. The honest answer surprises most teams, because the heaviest part of it is a public one.
How a Complaint Works
The complaint goes to the Ethics Committee for Pharmaceutical Marketing Practices, the ECPMP that every pharmaceutical association now runs. It has to be filed within six months of the alleged breach, with a small non-refundable deposit, and the company named gets thirty days to respond.
What the Committee Can Do
If a breach is established, the committee has a set of actions to choose from. It can suspend or expel the company from the association. It can reprimand the company and publish the full details of that reprimand. It can order a corrective statement in the same media that carried the original material. It can direct the company to recover money or items given in violation of the code. And where the matter needs a statutory authority, it can refer the case, through the Department of Pharmaceuticals, to an agency that can act. Either side can appeal to the Apex Committee, headed by the Secretary of the Department, whose decision is final and binding.
The Consequence That Lasts
Through all of it, the association puts the complaint, the company named, and the outcome on its own website and on the Department's portal, and it stays there for five years.
That last part is the part that matters. The consequence the code carries is a record, and the record is public. A reprimand published in full. A corrective statement run in the same journal that carried the claim. An outcome listed against the company name for five years, in front of the doctors the company sells to.
Above all of this sits one signature. Each year the senior-most executive of the company files a self-declaration that the company has complied with the code, and a 2024 standing order added an undertaking to comply in the year ahead. A finding against the company is a finding against a document that person put their name to. Separately, the tax authorities have disallowed expenses incurred in breach of the code, so a marketing choice can turn into a tax cost as well.
Where This Leaves the Brand Manager
For the brand manager, this moves where the risk actually sits. A reprinted collateral costs money, and money can be recovered. A reprimand published where doctors can read it costs the brand its standing with those doctors, and standing is much harder to win back. The cheapest place to settle a doubtful claim is the desk, before the page is ever printed. Once it is in the field and inside a complaint, the record is written by someone else.
Disclaimer: This is a practitioner reading of the code for brand teams, not legal advice. The final compliance call sits with your medical and regulatory team.